You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CMML

Showing 26 - 50 of 200
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in Houston (Decitabine and Cedazuridine, Venetoclax)

Recruiting
  • Chronic Myelomonocytic Leukemia
  • Myelodysplastic Syndrome
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Tampa (PF-04449913)

Completed
Has Results
  • Myelodysplastic Syndrome (MDS)
  • Chronic Myelomonocytic Leukemia (CMML)
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 10, 2021

MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Japan (Panobinostat)

Completed
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • Nagoya-city, Aichi, Japan
  • +5 more
Dec 16, 2020

Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML Trial in Germany (Cyclophosphamide, ATG)

Recruiting
  • Graft Vs Host Disease
  • +5 more
  • Augsburg, Germany
  • +15 more
Aug 2, 2022

Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,

Completed
  • Chronic Myelogenous Leukemia
  • +9 more
  • Atlanta, Georgia
    Northside Hospital
Apr 4, 2022

MDS Trial in France (Decitabine, HYDROXYUREA)

Completed
  • MDS
  • Saint-Denis, La Réunion, France
  • +44 more
Nov 17, 2021

Azacitidine in International Prognostic Scoring System

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
    • Hefei, Anhui, China
    • +16 more
    Sep 6, 2022

    CMML, Thrombocytopenia Trial in France (eltrombopag)

    Completed
    • CMML
    • Thrombocytopenia
    • Amiens, France
    • +25 more
    Apr 19, 2021

    GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

    Recruiting
    • GVHD
    • +15 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 30, 2021

    MDS, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Denmark (Vitamin C, Placebo)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Vitamin C
    • Placebo
    • Aalborg, Denmark
    • +5 more
    Sep 27, 2021

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Worldwide (Glasdegib, Azacitidine)

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • Salzburg, Austria
    • +17 more
    Dec 14, 2022

    MDS, Chronic Myelomonocytic Leukemia-1, Cytopenia Trial in Denmark, United States (Vitamin C (ascorbic acid), Placebo)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Vitamin C (ascorbic acid)
    • Placebo
    • Los Angeles, California
    • +4 more
    Sep 27, 2021

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +9 more
    • Los Angeles, California
    • +5 more
    Jan 27, 2023

    Leukemia, Myelodysplastic Syndrome Trial in Boston, Saint Louis (AZD6738)

    Recruiting
    • Leukemia
    • Myelodysplastic Syndrome
    • Boston, Massachusetts
    • +3 more
    Jan 13, 2021

    Chronic Myelomonocytic Leukemia (CMML) Trial in Tampa, Rochester (lenzilumab)

    Completed
    • Chronic Myelomonocytic Leukemia (CMML)
    • Tampa, Florida
    • +1 more
    Feb 26, 2020

    Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Duesseldorf (Lenalidomide, Azacitidine, Donor

    Completed
    • Leukemia, Myeloid, Acute
    • +2 more
    • Duesseldorf, NRW, Germany
      University Hospital Duesseldorf, Dept. of Hematology, Oncology a
    May 26, 2020

    MDS, CMML Trial in Florence (CC-486)

    Recruiting
    • MDS
    • CMML
    • Florence, Italy
      AOU Careggi- University of Florence
    Mar 16, 2021

    MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

    Recruiting
    • Myelodysplastic Syndromes
    • Myeloproliferative Chronic Myelomonocytic Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Registry on Hypomethylating Agents in Myeloid Neoplasms

    Active, not recruiting
    • Chronic Myelomonocytic Leukemia
    • +2 more
    • non interventional
    • Feldkirch, Austria
    • +19 more
    Jul 20, 2021

    Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,

    Active, not recruiting
    Has Results
    • Myelodysplastic Syndrome
    • +2 more
    • Daphne, Alabama
    • +241 more
    Dec 23, 2022

    MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Pevonedistat)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • +2 more
    • Birmingham, Alabama
    • +58 more
    Aug 24, 2022

    Myeloid Diseases Trial (DFV890)

    Not yet recruiting
    • Myeloid Diseases
    • (no location specified)
    Nov 11, 2022

    Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Finland (Bexmarilimab, Azacitidine, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Helsinki, Finland
    • +3 more
    Jun 29, 2022

    MDS, CMML, AML Trial in Canada, United States (SGI-110)

    Completed
    • MDS
    • +2 more
    • Scottsdale, Arizona
    • +15 more
    Apr 16, 2021

    MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (Guadecitabine, Treatment Choice)

    Completed
    • Myelodysplastic Syndromes
    • Leukemia, Myelomonocytic, Chronic
    • Duarte, California
    • +95 more
    Sep 1, 2021